Prodrug compounds with isoleucine
CA 2413149 A1 · Owner: Nieder, Matthew H. · Inventors: Pickford, Lesley B.; Lobl, Thomas J.; Gangwar, Sanjeev
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The compounds of the invention are modified forms of therapeutic agents. A typical prodrug compound of the invention comprises a therapeutic agent an , oligopeptide having an isoleucine residue a stabilizing group and, optionally, a linker group. The prodrug is cleavable by an enzyme associated with the target cell. Methods of making and using the compounds are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.